Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2026-01-02 @ 8:51 AM
Study NCT ID:
NCT01558869
Status:
COMPLETED
Last Update Posted:
2017-05-09
First Post:
2012-03-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Xeloxiri as First-line Treatment in Patients With Advanced Unresectable Pancreatic Adenocarcinoma
Sponsor:
The University of Hong Kong
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
MONC-HBP24
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None